Five key takeaways from the report:
- The report, which used data from 12,591 people who’ve received a third dose of either vaccine since the FDA authorized them for immunocompromised people in August, found no new serious or unexpected patterns of side effects emerging in people who get a booster.
- The data used in the CDC report comes from V-safe, the CDC’s reporting system in which people voluntarily report side effects through an app.
- The CDC report said that 79.4 percent of people getting a booster shot reported a local reaction, such as pain at the injection site, compared to 77.6 percent of people who reported that reaction after their second dose.
- After a third dose, 74.1 percent of people reported a systemic reaction, such as headache or fatigue, compared to 76.5 percent of people who reported that reaction after their second dose.
- “These initial findings indicate no unexpected patterns of adverse reactions after an additional dose of COVID-19 vaccine; most of these adverse reactions were mild or moderate,” the CDC report stated.
Find the full report here.
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
